Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development
Logo Image
|Articles|November 22, 2013

BBK Worldwide Builds on Tablet Function in Latest Version of Study eBinder

BBK Worldwide announced the latest version its Study eBinder

BBK Worldwide announced the latest version its Study eBinder, which addresses more customization for its tablet that study teams use. Version 3.0 provides more than 300 real-time reports and a protected instant messaging system for sponsors to connect directly with physician investigators and site staff in its proprietary patient recruitment portal, TrialCentralNet (TCN®). The new version also is fully customizable for the sponsor's brand and content.

You can read the full release here.

Related to this article

View more
What Needs to Happen Beyond the Clinical Trial Modernization Act
What Needs to Happen Beyond the Clinical Trial Modernization Act
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
Read more
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
Read more